Outcomes of empagliflozin in nondiabetic fatty liver patients: A randomized controlled trial

Authors

Institutions

Publication Details

Journal
Journal of Taibah University Medical Sciences
Published
2025-08-01
DOI
https://doi.org/10.1016/j.jtumed.2025.07.008
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outcomes of empagliflozin in nondiabetic fatty liver patients: A randomized controlled trial

tarek Mohamed Abdelrhman, Mohammad HM AbdEllah-Alawi, Marwa M. Abokresha, Zeinab M. Hassanein et al.
1 citations
Journal of Taibah University Medical Sciences
Liver Disease Diagnosis and Treatment
1.35
article

Outcomes of empagliflozin in nondiabetic fatty liver patients: A randomized controlled trial

tarek Mohamed Abdelrhman, Mohammad HM AbdEllah-Alawi, Marwa M. Abokresha, Zeinab M. Hassanein, Bahaa Osman Taha, M. A. Kobeisy, Essam Abdelmohsen
article en
1 citations

Abstract

No abstract available for this paper.
Journal of Taibah University Medical SciencesVol. 20(4)
Assiut University (EG)
Good health and well-being
Openalex Percentile: Top 17%
Liver Disease Diagnosis and Treatment
1.35
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Outcomes of empagliflozin in nondiabetic fatty liver patients: A randomized controlled trial — tarek Mohamed Abdelrhman, Mohammad HM AbdEllah-Alawi, et al. · Journal of Taibah University Medical Sciences (2025) | TGRS Research Map | TGRS